Table 3.
Management of symptomatic versus asymptomatic brain metastases
Treatment | Overall, n (%) | Asymptomatic, n (%) | Symptomatic, n (%) | P value |
---|---|---|---|---|
No treatment | 39 (18.3) | 0 (0) | 4 (11.4) | 1 |
Steroids | 32 (82.1) | 0 (0) | 32 (91.4) | <.001 |
Prior immunotherapy | 10 (25.6) | 0 (0) | 10 (28.6) | .56 |
Active immunotherapy | 3 (7.7) | 0 (0) | 3 (8.6) | 1 |
Stereotactic radiosurgery alone | 18 (46.2) | 4 (100) | 14 (40.0) | .04 |
Surgery | 9 (35.3) | 0 (0) | 9 (25.7) | .56 |
Hospitalization for brain met | 23 (59.0) | 0 (0) | 23 (65.7) | .02 |
Whole brain radiation therapy | 8 (20.5) | 0 (0) | 8 (22.9) | .56 |